It has been reported that breast cancer cells express elevated levels of LPAR1, LPAR2, and LPAR3 and that these LPA receptors are involved in stimulating tumorigenic and metastatic cascades via Wnt, MAPK, and PI3K pathways. This evidence concerns the gene LPAR3 and breast cancer.